Author

Manuel Romero-Gomez 1

1 Hospital Universitario de Valme, Universidad

99.7% SUSTAINED VIROLOGIC RESPONSE RATE IN 369 HCV GENOTYPE 1B-INFECTED PATIENTS TREATED WITH LABEL-RECOMMENDED REGIMEN OF OMBITASVIR/PARITAPREVIR/R AND DASABUVIR WITH OR WITHOUT RIBAVIRIN

Jean-François Dufour, Heiner Wedemeyer, David E. Bernstein, Massimo Colombo, Manuel Romero-Gomez, Nancy Reau, Roger Trinh, Wangang Xie, Jeffrey Enejosa, Daniel E. Cohen, Marisol Martinez, Ira M. Jacobson

Current and future medical treatment

Manuel Romero-Gomez

LOW INCIDENCE OF HYPERBILIRUBINAEMIA EVENTS WITH ABT-450/R/OMBITASVIR AND DASABUVIR WITH OR WITHOUT RIBAVIRIN IN HCV GENOTYPE-1 INFECTED PATIENTS

Manuel Romero-Gomez, Rui Tato Marinho, Ramon Vila, David E. Bernstein, Federico Rodriguez-Perez, Tarek Hassanein, K. Reddy, Naoky Tsai, Sandra Lovell, Jeffrey Enejosa, Yan Luo, Daniel E. Cohen, Marcos Pedrosa, Massimo Colombo

Mistakes in nonalcoholic fatty liver disease

Manuel Romero-Gomez

SVR12 OF 99% ACHIEVED WITH A RIBAVIRIN-FREE REGIMEN OF ABT-450/R/OMBITASVIR AND DASABUVIR IN HCV GENOTYPE 1B-INFECTED PATIENTS

Andreas Maieron, Massimo Puoti, Jeffrey Enejosa, Ziv Ari, Gunnar Norkrans, Manuel Romero-Gomez, Daniel E. Cohen, Thomas Podsadecki

Item 1 - 5 / 5
1